Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines.
- DOI
- 10.1002/jmv.29927
- Published
- 2024 Sep
- Container
- Journal of medical virology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/jmv.29927,
title = {Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines.},
author = {Lovell JF and Miura K and Baik YO and Lee C and Choi Y and Her H and Lee JY and Ylade M and Lee-Llacer R and De Asis N and Trinidad-Aseron M and Ranola JM and De Jesus LZ},
year = {2024},
journal = {Journal of medical virology},
doi = {10.1002/jmv.29927},
url = {https://doi.org/10.1002/jmv.29927}
}RIS
TY - JOUR TI - Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines. AU - Lovell JF AU - Miura K AU - Baik YO AU - Lee C AU - Choi Y AU - Her H AU - Lee JY AU - Ylade M AU - Lee-Llacer R AU - De Asis N AU - Trinidad-Aseron M AU - Ranola JM AU - De Jesus LZ PY - 2024 JO - Journal of medical virology DO - 10.1002/jmv.29927 UR - https://doi.org/10.1002/jmv.29927 ER -
APA
JF, L., K, M., YO, B., C, L., Y, C., H, H., JY, L., M, Y., R, L., N, D. A., M, T., JM, R., & LZ, D. J. (2024). Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines.. Journal of medical virology. https://doi.org/10.1002/jmv.29927
Source records
- pubmed · retrieved 2026-09-27T12:13:42.359Z